CAPTRUST Financial Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,402
| Closed | -$41K | – | 2994 |
|
|
2022
Q2 | $41K | Sell |
1,402
-675
| -32% | -$19.7K | ﹤0.01% | 2907 |
|
|
2022
Q1 | $72K | Buy |
2,077
+197
| +10% | +$6.83K | ﹤0.01% | 2517 |
|
|
2021
Q4 | $82K | Buy |
1,880
+743
| +65% | +$32.4K | ﹤0.01% | 2315 |
|
|
2021
Q3 | $58K | Buy |
1,137
+260
| +30% | +$13.3K | ﹤0.01% | 2478 |
|
|
2021
Q2 | $46K | Buy |
877
+352
| +67% | +$18.5K | ﹤0.01% | 2562 |
|
|
2021
Q1 | $24K | Hold |
525
| – | – | ﹤0.01% | 2888 |
|
|
2020
Q4 | $24K | Hold |
525
| – | – | ﹤0.01% | 2167 |
|
|
2020
Q3 | $21K | Buy |
+525
| New | +$21K | ﹤0.01% | 1949 |
|